Multimodality Imaging of Somatostatin Receptor–Positive Tumors with Nuclear and Bioluminescence Imaging
Stefan Pool(Erasmus MC), Gerben A. Koning(Università Cattolica del Sacro Cuore), Marion de Jong(Shell (Netherlands)), Stuart Koelewijn(Erasmus MC), Timo L.M. ten Hagen(Erasmus MC)
Cited by 4
Related Papers
TNF-α in Cancer Treatment: Molecular Insights, Antitumor Effects, and Clinical Utility
|The Oncologist|2006|711
[177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients
|European Journal of Nuclear Medicine and Molecular Imaging|2001|471
Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
|Endocrine Related Cancer|2009|462
Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors
|Cancer Research|2012|458
Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide: The rotterdam experience
|Seminars in Nuclear Medicine|2002|433